Öйú365betÖÐÎĹÙÍø

WASHINGTON, April 24, 2018 â€� The American Chemical Öйú365betÖÐÎĹÙÍø (ACS) expresses concern about the proposed changes announced today by the U.S. Environmental Protection Agency Administrator Scott Pruitt. The changes may result in exclusion of confidential human health studies that can be used to implement regulations to safeguard the American public.

ACS believes federal agencies should collect, evaluate and use scientific information in a consistent and timely manner while protecting intellectual property rights, confidential company information and the privacy of personal information. The proposed changes may adversely affect EPA’s ability to access vital scientific evidence while protecting these types of sensitive information.

“Insightful, comprehensive scientific input is critical to the development of government policies and regulations,� says Glenn S. Ruskin, director, ACS External Affairs & Communications. “EPA has a well-regarded process for incorporating vital scientific insights into regulations. Any changes must ensure that EPA retains the ability to access and utilize the most appropriate sources of scientific information, while protecting important proprietary and personal information.�

ACS intends to register a formal public comment regarding the proposed changes. The Öйú365betÖÐÎĹÙÍø stands ready to work with EPA and other members of the scientific community to ensure the agency’s ability to obtain and use relevant scientific information.

ACS� comprehensive policy priorities, individual public policy statements and related materials are available at .

The American Chemical Öйú365betÖÐÎĹÙÍø, the world’s largest scientific society, is a not-for-profit organization chartered by the U.S. Congress. ACS is a global leader in providing access to chemistry-related information and research through its multiple databases, peer-reviewed journals and scientific conferences. ACS does not conduct research, but publishes and publicizes peer-reviewed scientific studies. Its main offices are in Washington, D.C., and Columbus, Ohio.